Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00027586
What this trial is testing

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Large-scale testing (Phase 3)UnknownNCT00052156
What this trial is testing

Vaccine Therapy for Patients With Stage IV Melanoma

Who this might be right for
Malignant Melanoma
CancerVax Corporation 670
Testing effectiveness (Phase 2)Ended earlyNCT02009384
What this trial is testing

Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox

Who this might be right for
Metastatic Melanoma
University of Louisville 2
Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Large-scale testing (Phase 3)Ended earlyNCT00522834
What this trial is testing

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

Who this might be right for
Melanoma
Synta Pharmaceuticals Corp. 630
Testing effectiveness (Phase 2)Ended earlyNCT02410863
What this trial is testing

Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 10
Testing effectiveness (Phase 2)Study completedNCT01253564
What this trial is testing

RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01136967
What this trial is testing

An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage IIIStage IV Melanoma
Eisai Inc. 182
Testing effectiveness (Phase 2)Study completedNCT01835145
What this trial is testing

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Study completedNCT00109005
What this trial is testing

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT00087373
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Testing effectiveness (Phase 2)Study completedNCT00005875
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06295159
What this trial is testing

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVAdvanced Melanoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 90
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00256282
What this trial is testing

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Melanoma
John P. Fruehauf 52
Not applicableActive Not RecruitingNCT07428252
What this trial is testing

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Institute of Oncology Ljubljana 150
Early research (Phase 1)Ended earlyNCT00667901
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
University of Medicine and Dentistry of New Jersey 15
Next Page